DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period.
A 23 year old woman with diabetes insipidus who had previously been treated with pitressin, pituitary snuff and chlorpropamide, was treated with DDAVP during pregnancy. DDAVP concentrations immunoassayed as vasopressin were determined in maternal serum and breast milk. Oxytocin antibodies were also determined in maternal serum.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000032:analysis / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008895:Milk, Human / Q000032:analysis; D010121:Oxytocin / Q000276:immunology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*
D000906:Antibodies; D001127:Arginine Vasopressin; D010121:Oxytocin; D003894:Deamino Arginine Vasopressin